Predicting and designing therapeutics against the Nipah virus
Submitted by susan on Thu, 2019-12-19 12:48
Despite Nipah virus outbreaks having high mortality rates (>70% in Southeast Asia), there are no licensed drugs against it. In this study, we have considered all 9 Nipah proteins as potential therapeutic targets and computationally identified 4 putative peptide inhibitors (against G, F and M proteins) and 146 small molecule inhibitors (against F, G, M, N, and P proteins).
Main Topic:
Mark Content Private(Internal):
Email Alert:
1-23
Publication Date:
12/12/2019